Novartis has pulled its TV ad for Lamisil from the air after receiving a letter from the FDA objecting to the sequence in which Novartis presents the qualifying and efficacy information for its anti-fungal.
25.1% of Patients Cited “Less Noticeable” Vitiligo in Recent Study
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Indoor Tanning and Melanoma
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
Oral Ivarmacitinib Demonstrates Significant Atopic Dermatitis Improvement
Annual Meeting Session Highlights Clinical Pearls in Medical Dermatology